The role of integrins in osteoclast function

Journal of Bone and Mineral Metabolism

Volumn 17, Issue 1, 1999, Pages 1-6

  Duong, Le T ^a   Rodan, Gideon A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bone resorption; Cytoskeleton; Sealing zone; Tyrosine phosphorylation; Vitronectin receptor v 3

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FOCAL ADHESION KINASE; INTEGRIN; SCLEROPROTEIN; VITRONECTIN RECEPTOR;

ANIMAL CELL; BONE MATRIX; CELL ADHESION; CELL FUNCTION; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BONE RESORPTION; CELL ADHESION; CELL MOVEMENT; CELL POLARITY; CYTOSKELETON; FOCAL ADHESION KINASE 2; HUMANS; INTEGRINS; MODELS, BIOLOGICAL; OSTEOCLASTS; PROTEIN-TYROSINE KINASES; RECEPTORS, VITRONECTIN; SIGNAL TRANSDUCTION;

EID: 0033052857     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007740050055     Document Type: Review

References (42)

1. Suda T, Nakamura I, Jimi E, Takahashi N (1997) Regulation of osteoclast function. J Bone Miner Res 12:869-879
2. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
3. Clark EA, Brugge JS (1995) Integrins and signal transduction pathways: the road taken. Science 268:233-239
4. Schlaepfer DD, Hunter T (1998) Integrin signalling and tyrosine phosphorylation: just the FAKs. Trends Cell Biol 8:151-157
5. Yamada KM, Miyamoto S (1995) Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 7:681-689
6. Horton MA (1997) The alpha v beta 3 integrin "vitronectin receptor." Int J Biochem Cell Biol 29:721-725
7. Horton MA, Rodan GA (1996) Integrins as therapeutic targets in bone disease. In: Horton MA (ed) Adhesion receptors as therapeutic targets. CRC Press, Boca Raton, pp 223-245
8. Buckley CD, Doyonnas R, Newton JP, Blystone SD, Brown EJ, Watt SM, Simmons DL (1996) Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci 109:437-445
9. Ebeling O, Duczmal A, Aigner S, Geiger C, Schollhammer S, Kemshead JT, Moller P, Schwartz Albiez R, Altevogt P (1996) L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin. Eur J Immunol 26:2508-2516
10. Chambers TJ, Fuller K, Darby JA, Pringle JAS, Horton MA (1986) Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner 1:127-135
11. Davies J. Warwick J, Totty N, Philp R, Helfrich M, Horton M (1989) The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 109:1817-1826
12. Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ (1990) Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol 111:1713-1723
13. Horton MA, Taylor ML, Arnett TR, Helfrich MH (1991) Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 195:368-375
14. Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RH, Garsky VM, Rodan GA, Rosenblatt M (1993) Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein. Endocrinology 132:1411-1413
15. King KL, D'Anza JJ, Bodary S, Pitti R, Siegel M, Lazarus RA, Dennis MS, Hammonds RG Jr, Kukreja SC (1994) Effects of kistrin on bone resorption in vitro and serum calcium in vivo. J Bone Miner Res 9:381-387
16. Masarachia P, Yamamoto M, Leu C-T, Rodan GA, Duong LT (1998) Direct demonstration of the inhibitory effect of echistatin on bone resorption in mice with secondary hyperparathyroidism. Endocrinology 139:1401-1410
17. Crippes BA, Engleman VW, Settle SL, Delarco J, Ornberg RL, Helfrich MH, Horton MA, Nickols GA (1996) Antibody to beta(3) integrin inhibits osteoclast mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology 137:918-924
18. Engleman VW, Nickols GA, Ross FP, Horton MA, Griggs DW, Settle SL, Ruminski PG, Teitelbaum SL (1997) A peptidomimetic antagonist of the alpha v beta 3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest 99:2284-2292
19. Yamamoto M, Fisher JE, Gentile M, Scedor JG, Leu C-T, Rodan SB, Rodan GA (1998) The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Endocrinology 139:1411-1419
20. Nesbitt S, Nesbit A, Helfrich M, Horton M (1993) Biochemical characterization of human osteoclast integrins. Osteoclasts express αvβ3, α2β1, and αvβ1 integrins. J Biol Chem 268:16737-16745
21. Tanaka H, Sato M, Shinar D, Rodan GA (1991) Echistatin inhibits osteoclast-like cell generation in the co-culture system of mouse osteoblastic cells and bone marrow cells. J Bone Miner Res 6:S148
22. Reinholt FP, Hultenby K, Oldberg A, Heinegard D (1990) Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475
23. Nakamura I, Gailit J, Sasaki T (1996) Osteoclast integrin αvβ3 is present in the clear zone and contributes to cellular polarization. Cell Tissue Res 286:507-515
24. Zambonin Zallone A, Teti A, Gaboli M, Marchisio PC (1989) Beta 3 subunit of vitronectin receptor is present in osteoclast adhesion structures and not in other monocyte-macrophage derived cells. Connect Tissue Res 20:143-149
25. Lakkakorpi PT, Horton MA, Helfrich MH, Karhukorpi EK, Väänänen HK (1991) Vitronectin receptor has a role in bone resorption but does not mediate tight scaling zone attachment of osteoclasts to the bone surface. J Cell Biol 115:1179-1186
26. Paniccia R, Riccioni T, Zani BM, Zigrino P, Scotlandi K, Teti A (1995) Calcitonin down-regulates immediate cell signals induced in human osteoclast-like cells by the bone sialoprotein-IIA fragment through a postintegrin receptor mechanism. Endocrinology 136:1177-1186
27. i in rat osteoclasts and mouse-derived osteoclast-like cells. Am J Physiol 266:C376-C381
28. Shankar G, Gadek TR, Burdick DJ, Davison I, Mason WT, Horton MA (1995) Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions. Exp Cell Res 219:364-371
29. Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702
30. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR (1992) Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627
31. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R (1996) c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature (Lond) 383:528-531
32. FAK, in osteoclastic bone resorption. J Cell Biochem 58:424-435
33. Berry V, Rathod H, Pulman LB, Datta HK (1994) Immunofluorescent evidence for the abundance of focal adhesion kinase in the human and avian osteoclasts and its down regulation by calcitonin. J Endocrinol 141:R11-R15
34. Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA (1997) PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of αvβ3 integrin, and associated with Src kinase. J Clin Inv 102:881-892
35. Levy JB, DiDomenico E, Neff L, Dikic I, Schlessinger J, Baron R (1997) The FAK-related kinase, Pyk2, is tyrosine phosphorylated in response to integrin stimulation in osteoclasts. J Bone Miner Res 12:S109
36. cas is involved in actin organization in osteoclasts. J Biol Chem 273:11144-11149
37. cas with Pyk2 in osteoclasts. Mol Biol Cell 8 (suppl):397a
38. Hruska KA, Rolnick F, Huskey M, Alvarez U, Cheresh D (1995) Engagement of the osteoclast integrin αvβ3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Ann N Y Acad Sci 760:151-165
39. Chellaiah M, Hruska K (1996) Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. Mol Biol Cell 7:743-753
40. Dodge JA, Bryant HU, Kim J, Matter WF, Norman BH, Srinivasan U, Vlavos CJ, Sato M (1995) 17-Beta-hydroxywortmannin: a posten inhibitor of bone resorption and phosphatidyl 3-kinase. Bioorg Med Chem Lett 5:1713-1718
41. Nakamura I, Takahashi N, Sasaki T, Tanaka S, Ugadawa N, Murakami H, Kimura K, Kabuyama Y, Kurokawa T, Suda T, Fukui Y (1995) Wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase, blocks osteoclastic bone resorption. FEBS Lett 361:79-84
42. Zhang D, Udagawa N, Nakamura I, Murakami H, Saito S, Yamasaki K, Shibasaki Y, Morii N, Narumiya S, Takahashi N, Suda T (1995) The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J Cell Sci 108:2285-2292